Kalamazoo, MI, United States of America

Moo J Cho


Average Co-Inventor Count = 1.5

ph-index = 3

Forward Citations = 107(Granted Patents)


Company Filing History:


Years Active: 1979-1989

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Moo J Cho: Innovator in Pharmaceutical Chemistry

Introduction

Moo J Cho is a notable inventor based in Kalamazoo, MI (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. With a total of 3 patents to his name, Cho's work has the potential to impact various medical treatments.

Latest Patents

One of Cho's latest patents is focused on N-substituted derivatives of 2-(pyridylalkenesulfinyl) benzimidazoles. This invention provides novel compounds that exhibit gastric acid inhibiting effects, which could be beneficial in treating conditions related to excessive stomach acid. Another significant patent involves the stabilization of PGI.sub.2 compounds with surfactants. This invention outlines methods for stabilizing aqueous solutions of prostacyclin and its analogs by incorporating neutral or cationic surfactants. Additionally, it describes novel pharmaceutical compositions that utilize these surfactant-containing solutions.

Career Highlights

Moo J Cho is currently associated with The Upjohn Company, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing the understanding and application of complex chemical compounds in medicine.

Collaborations

Throughout his career, Cho has collaborated with esteemed colleagues, including John J Biermacher and John C Sih. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.

Conclusion

Moo J Cho's contributions to pharmaceutical chemistry through his innovative patents demonstrate his commitment to advancing medical science. His work not only showcases his expertise but also holds promise for future therapeutic advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…